 | Up a level |
Journal Article
Ataseven, B., Rhiem, K., Staniczok, C., Heitz, F., Pauly, N., Moubarak, M., Concin, N., Traut, A., Schmutzler, R. and Harter, P. (2022). Prevalence and oncological outcome of patients with primary epithelial ovarian cancer (EOC) carrying gene mutations or variants of unknown signifikance (VUS) detected by germline gene panel testing. Geburtshilfe Frauenheilkd., 82 (10). S. E44 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Heitz, F., Ataseven, B., Moubarak, M., Staniczok, C., Schmutzler, R., Schameis, R., Heikaus, S., Concin, N., Riehm, K., Denkert, C. and Harter, P. (2022). HRD Testing and BRCA1/2 Germline Testing in Routine Clinical Practice in Patients with primary Ovarian Cancer. Geburtshilfe Frauenheilkd., 82 (10). S. E86 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Staniczok, C., Ataseven, B., Heitz, F., Harter, P., Rhiem, K., Pauly, N., Traut, A. and Moubarak, M. (2022). Prevalence and clinical characterization of concurrent multiple deleterious germline mutations in German patients with epithelial ovarian cancer. Geburtshilfe Frauenheilkd., 82 (10). S. E165 - 2. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804